Phillip Giles’s analysis published on 25 November 2025 examines the evolution of medical stop-loss group captives towards more coordinated cost-control arrangements. It argues for selective participation, aligned partners and programme-manager accountability, and discusses the implications when members implement different levels of cost control. This is an update to the earlier GBV discussion of risk retention and exit terms. The emphasis here is the operational programme and its participation criteria.